ECSP045181A - SYSTEM OF ADMINISTRATION OF DRUGS THAT INCLUDE RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES - Google Patents

SYSTEM OF ADMINISTRATION OF DRUGS THAT INCLUDE RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES

Info

Publication number
ECSP045181A
ECSP045181A ECSP045181A ECSP045181A EC SP045181 A ECSP045181 A EC SP045181A EC SP045181 A ECSP045181 A EC SP045181A EC SP045181 A ECSP045181 A EC SP045181A
Authority
EC
Ecuador
Prior art keywords
prevention
treatment
derivatives
drugs
administration
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Margaret Forney Prescott
Walter Schuller
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP045181A publication Critical patent/ECSP045181A/en

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan sistemas de administración de fármacos para la prevención y tratamiento de enfermedades proliferativas, particularmente enfermedades vasculares, comprendiendo dichos métodos rapamicina y derivados de rapamicina que tienen propiedades de inhibición de mTOR, opcionalmente en conjunto con uno o más co-agentes.Drug delivery systems are provided for the prevention and treatment of proliferative diseases, particularly vascular diseases, said methods comprising rapamycin and rapamycin derivatives having mTOR inhibition properties, optionally in conjunction with one or more co-agents.

ECSP045181 2001-01-10 2004-06-09 SYSTEM OF ADMINISTRATION OF DRUGS THAT INCLUDE RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES ECSP045181A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34726401P 2001-01-10 2001-01-10

Publications (1)

Publication Number Publication Date
ECSP045181A true ECSP045181A (en) 2004-08-27

Family

ID=40445786

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045181 ECSP045181A (en) 2001-01-10 2004-06-09 SYSTEM OF ADMINISTRATION OF DRUGS THAT INCLUDE RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES

Country Status (1)

Country Link
EC (1) ECSP045181A (en)

Similar Documents

Publication Publication Date Title
ECSP085181A (en) DRUG ADMINISTRATION SYSTEM THAT INCLUDES RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES
WO2005011734A3 (en) Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer
AU6158001A (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
LTC1765293I2 (en) Pharmaceutical compositions for the delivery of medicaments and methods for treating or preventing conditions using these compositions
WO2006060547A3 (en) Systems and methods for intra-oral drug delivery
DE60026532D1 (en) SCREENING METHOD FOR INHIBITORS OF ACRAB AND ACRAB-SIMILAR OUTFLOW PUMPS
CL2007002261A1 (en) COMPOUNDS DERIVED FROM IMIDAZO [1,2-B] PIRIDAZINA, QUINASA INHIBITORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF CANCER.
EA200401252A1 (en) MICROPARTICLES OF MEDICINAL SUBSTANCES
EP1611880A3 (en) Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
MXPA03010085A (en) Composition and methods for treatment of hyperplasia.
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
ATE347901T1 (en) EXENDINE FOR GLUCAGON SUPPRESSION
DE60118547D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLORECTAL CANCER, WHICH CONTAINS THALIDOMIDE AND IRINOTECANE
ECSP055788A (en) DRUG SUPPLY SYSTEM
DE60137960D1 (en) PHARMACEUTICAL COMPOSITIONS WITH CORTICOSTEROIDES AND ANTI-INFECTIVES
ATE307625T1 (en) DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF VASCULAR DISEASES
NO20055173L (en) Pharmaceutical combination combination comprising modafinil and another drug
NO20044156L (en) New 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, processes for the preparation of the same, and pharmaceutical preparations containing the same
AR034493A1 (en) COMBINATION OF ACTIVE PRINCIPLES FOR THE MEDICAL TREATMENT OF TOXICOMANS.
ECSP045181A (en) SYSTEM OF ADMINISTRATION OF DRUGS THAT INCLUDE RAPAMYCIN AND DERIVATIVES OF THE SAME FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES
BRPI0506630A (en) controlled release composition and method for administering a controlled release transmucosal aqueous drug
BRPI0608917A2 (en) ANTIBIOTIC CONTROLLED RELEASE COMPOSITION AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTION
NO20075508L (en) Stable Soporphine Preparations and Administration
HK1069990A (en) Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
WO2005011589A3 (en) Drug delivery methods and devices